Inhibition of Sema4D or downregulation of plexinB1 resulted in RhoA/ROCK pathway inhibition and could reduce VM formation in human NSCLC cell lines (Xia et al., 2019). The gene discussed is PLXNB1; the disease is non-small cell lung carcinoma.